Oppenheimer Holdings Inc.
Location
New York
Founded
1881-02-13
Website
Risk Signals
763 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Security Brokers, Dealers, and Flotation Companies, Offices of Bank Holding Companies, Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Oppenheimer Holdings Inc.
Live alerts from global media, monitored by Business Radar
2025-06-23 (marketbeat.com)
Oppenheimer & Co. Inc. Sells 11,452 Shares of Enbridge Inc (NYSE:ENB)
Oppenheimer & Co. Inc. decreased its stake in shares of Enbridge Inc (NYSE:ENB - Free Report) (TSE:ENB) by 3.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 374,812 shares of the pipeline company's stock after selling 11,452 shares during the period. Oppe
Read more
2025-06-23 (marketbeat.com)
Oppenheimer & Co. Inc. Has $30.26 Million Stock Position in Quanta Services, Inc. (NYSE:PWR)
Oppenheimer & Co. Inc. lessened its holdings in shares of Quanta Services, Inc. (NYSE:PWR - Free Report) by 5.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 119,067 shares of the construction company's stock after selling 7,104
Read more
2025-06-15 (marketbeat.com)
Asio Capital LLC Has $3.79 Million Stock Position in Crocs, Inc. (NASDAQ:CROX)
Asio Capital LLC boosted its holdings in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) by 15.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,698 shares of the textile maker's stock
Read more
2025-04-14 (investing.com)
Cue Biopharma launches public placement of shares from Investing.com
Investing.com - Cue Biopharma, Inc. (NASDAQ :), a biotechnological company at a clinical stage with a market capitalization of $ 47.6 million, announced today the start of the guaranteed public placement of shares of ordinary shares and related warrants. The completion and conditions of placement depend on market conditions, and no guarantees regarding its completion or specific conditions of the proposal were provided. According to InvestingPro, the company currently quickly consumes cash, which makes this placement to be critical for its activities.
Read more
2025-04-04 (marketbeat.com)
Vanguard Group Inc. Purchases 2,900 Shares of MercadoLibre, Inc. (NASDAQ:MELI)
Vanguard Group Inc. increased its position in MercadoLibre, Inc. (NASDAQ:MELI - Free Report) by 1.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 205,628 shares of the company's stock after buying an additional 2,900 shares during the period. Vanguard Gro
Read more
2025-04-01 (marketbeat.com)
Thomas J. Herzfeld Advisors Inc. Cuts Holdings in Sound Point Meridian Capital, Inc. (NYSE:SPMC)
Thomas J. Herzfeld Advisors Inc. lessened its stake in shares of Sound Point Meridian Capital, Inc. (NYSE:SPMC - Free Report) by 20.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 334,544 shares of the company's stock after selling 87,155 shares durin
Read more
2025-02-01 (citybiz.co)
Oppenheimer Holdings Reports Fourth Quarter and Full Year 2024 Earnings |
Oppenheimer Holdings Inc. (NYSE: OPY) today reported net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of... Read More
Read more
2025-02-01 (citybiz.co)
Oppenheimer Holdings Reports Fourth Quarter and Full Year 2024 Earnings |
Oppenheimer Holdings Inc. (NYSE: OPY) today reported net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of... Read More
Read more
2025-01-31 (stocktitan.net)
Oppenheimer Holdings Posts Record $1.4B Revenue, Full-Year Profit Surges 137% | OPY Stock News
Oppenheimer achieves record FY2024 with $71.6M net income, driven by strong advisory fees and AUM reaching $49.4B. Q4 shows robust 21.8% revenue growth despite cost pressures.
Read more
2025-01-31 (stocktitan.net)
Oppenheimer Holdings Posts Record $1.4B Revenue, Full-Year Profit Surges 137% | OPY Stock News
Oppenheimer achieves record FY2024 with $71.6M net income, driven by strong advisory fees and AUM reaching $49.4B. Q4 shows robust 21.8% revenue growth despite cost pressures.
Read more
2025-01-11 (marketbeat.com)
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) Position Increased by ORG Partners LLC
ORG Partners LLC raised its holdings in shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD - Free Report) by 811.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,498 shares of the company'
Read more
2024-12-29 (defenseworld.net)
State Street Corp Grows Position in Vivid Seats Inc. (NASDAQ:SEAT) -
Read State Street Corp Grows Position in Vivid Seats Inc. (NASDAQ:SEAT) at Defense World
Read more